The reconciliations with the appropriate GAAP measures can be found in our earnings release issued yesterday afternoon. You know, I think we'll be allocating capital to the plan more going forward. In many basins, you know, the team was able to, you know, increase productivity in 2025 versus 2024 on the oil side. You know, in general, it feels like investors, you know, over time, you know, want some form of growth.
At some point, you know, organic growth is gonna come into the equation. You know, I think there's probably a world where if we can efficiently allocate capital and growth becomes kind of the output, you know, that's probably a good decision. There could be a world where we hold CapEx flat and see what growth, you know, comes out of it. You know, we look at both of those things, PV and rate of return, and try to find a nice balance there.
From my understanding, the capital efficiency on using surfactants in your workovers is quite exceptional. If we, you know, do better than midpoint or towards the low end, that means we have, you know, high capital efficiency. You know, certainly have a solid DUC backlog that we can, you know, push or pull on, depending on the macro, I think that's gonna be a management decision. You know, I think there's some goals to be set for the teams, and we're already well on our way to achieving them, but I just don't think they're gonna run through guidance yet.